OTHER GROUP COMPANIES
market

Anuh Pharma ends marginally higher; WHO suspends drug

The scrip opened at Rs. 176.3 and has touched a high and low of Rs. 179.7 and Rs. 159 respectively.

April 21, 2016 4:51 IST | India Infoline News Service
Anuh Pharma Ltd ended 0.40% higher at Rs. 176.60 on BSE. The company said in a BSE filing that in view of the EDQM suspension, the WHO PQ authorities have suspended Pyrazinamide and Sulfadoxine from the WHO list of prequalified API’s until the WHO led inspection.

The scrip opened at Rs. 176.3 and has touched a high and low of Rs. 179.7 and Rs. 159 respectively. So far 134283(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 440.74 crore.

The BSE group 'XC' stock of face value Rs. 5 has touched a 52 week high of Rs. 414.75 on 12-Aug-2015 and a 52 week low of Rs. 174.1 on 20-Apr-2016. Last one week high and low of the scrip stood at Rs. 179.5 and Rs. 174.1 respectively.

The promoters holding in the company stood at 70.98 % while Institutions and Non-Institutions held 0 % and 29.02 % respectively.

The stock is currently trading below its 200 DMA.

Invest wise with Expert advice

FEATURED ARTICLE

BLOGS

Open Demat Account

Invest wise with Expert advice

By continuing, I accept the Terms & Conditions and agree to receive updates on Whatsapp